Chad J. Warren

CYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition Profiles

Vikas Kumar, Jan L. Wahlstrom, Dan A. Rock et al. · Drug Metabolism and Disposition · 2006 · 132 citations

Medicine, Pharmacokinetics, Pharmacology +16

Discovery of Potent Inhibitors of Soluble Epoxide Hydrolase by Combinatorial Library Design and Structure-Based Virtual Screening

Xing Li, Joseph J. McDonald, Steve A. Kolodziej et al. · Journal of Medicinal Chemistry · 2011 · 56 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Enzyme Source Effects on CYP2C9 Kinetics and Inhibition

Vikas Kumar, Dan A. Rock, Chad J. Warren et al. · Drug Metabolism and Disposition · 2006 · 56 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)

Chris P. Carron, John I. Trujillo, Kirk L. Olson et al. · ACS Medicinal Chemistry Letters · 2010 · 25 citations

Life Sciences, Immunology, Pharmacology +17

Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment

Jan L. Wahlstrom, Po‐Chang Chiang, Sarbani Ghosh et al. · Nanoscale Research Letters · 2007 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17